Dr. Lal PathLabs Limited Share Price Bombay S.E.

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Market Closed - Bombay S.E. 11:19:51 26/04/2024 BST 5-day change 1st Jan Change
2,387 INR +2.40% Intraday chart for Dr. Lal PathLabs Limited +8.19% -7.28%

Financials

Sales 2024 * 22.36B 268M 21.47B Sales 2025 * 24.94B 299M 23.94B Capitalization 198B 2.38B 190B
Net income 2024 * 3.57B 42.81M 3.43B Net income 2025 * 4.16B 49.88M 3.99B EV / Sales 2024 * 8.53 x
Net cash position 2024 * 7.72B 92.65M 7.42B Net cash position 2025 * 10.99B 132M 10.55B EV / Sales 2025 * 7.51 x
P/E ratio 2024 *
55.8 x
P/E ratio 2025 *
48 x
Employees 4,048
Yield 2024 *
0.72%
Yield 2025 *
0.77%
Free-Float 43.28%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.40%
1 week+8.19%
Current month+5.50%
1 month+5.25%
3 months-0.57%
6 months+1.62%
Current year-7.28%
More quotes
1 week
2 228.80
Extreme 2228.8
2 399.50
1 month
2 168.80
Extreme 2168.8
2 399.50
Current year
1 943.20
Extreme 1943.2
2 663.85
1 year
1 888.85
Extreme 1888.85
2 766.85
3 years
1 762.70
Extreme 1762.7
4 243.00
5 years
950.10
Extreme 950.1
4 243.00
10 years
696.50
Extreme 696.5
4 243.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 30/09/16
Director of Finance/CFO - 31/12/05
Chairman 74 13/02/95
Members of the board TitleAgeSince
Director/Board Member 58 26/07/23
Director/Board Member 77 20/08/15
Chairman 74 13/02/95
More insiders
Date Price Change Volume
26/04/24 2,387 +2.40% 17,356
25/04/24 2,331 0.00% 7,026
24/04/24 2,331 +3.73% 4,981
23/04/24 2,247 -0.85% 4,501
22/04/24 2,266 +2.73% 3,370

Delayed Quote Bombay S.E., April 26, 2024 at 11:19 am

More quotes
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
2,388 INR
Average target price
2,455 INR
Spread / Average Target
+2.78%
Consensus